Hematology-Oncology

Get The App!

Featured Programs

Latest Immunotherapy Advances in RCC: Integrating Data from the 2021 Winter Meeting into Clinical Practice

6 episodes - 1.00 credit hours

Various Speakers

Immunotherapy Advances in Urothelial Cancer: Integrating Data from the Winter 2021 Meeting into Clinical Practice

7 episodes - 1.00 credit hours

Various Speakers

Improving Patient Care and Communication: Best Practices

4 episodes - non-certified

Thomas W. LeBlanc, MD, MA, MHS, FAAHPM

Highlights in Hematologic Malignancies from the Winter 2020 Hematology Meeting - Integrating Data into Clinical Practice

9 episodes - 1.25 credit hours

Various Speakers

Test Your Knowledge:

Are You Smarter Than the Average ED Doctor When Dealing With Anticoagulation?

See More Quizzes

Featured Areas of Interest

Best Practices During COVID-19 3 items

Translating CAT Guidelines into Everyday Practice During COVID-19

8 episodes - 1.25 credit hours

Various Speakers

"Best Practice" Information During the Rapidly Evolving Era of COVID-19

11 episodes - 2.00 credit hours

Various Speakers

Navigating First-Line Checkpoint Inhibitor Combinations in Non-Small Cell Lung Cancer (NSCLC) in the Era of COVID-19

12 episodes - 2.00 credit hours

Various Speakers

Immuno-Oncology View All (18)

Latest Immunotherapy Advances in RCC: Integrating Data from the 2021 Winter Meeting into Clinical Practice

6 episodes - 1.00 credit hour

Various Speakers

Immunotherapy Advances in Urothelial Cancer: Integrating Data from the Winter 2021 Meeting into Clinical Practice

7 episodes - 1.00 credit hour

Various Speakers

Highlights in Hematologic Malignancies from the Winter 2020 Hematology Meeting - Integrating Data into Clinical Practice

9 episodes - 1.25 credit hours

Various Speakers

The Evolving Role of Checkpoint Inhibitors as Frontline Treatment for Malignant Pleural Mesothelioma

7 episodes - 1.00 credit hour

Patrick Forde, MBBCh & Joshua Reuss, MD

IO On The GO Series: Clinical Questions and Latest Approaches in Hepatocellular Carcinoma (HCC)

5 episodes - 1.00 credit hour

Various Speakers

Advancing the Care of ß-thalassemia Patients with Novel Therapies

14 episodes - 1.75 credit hours

Various Speakers

Impacting Patient Outcomes in mRCC

9 episodes - 1.50 credit hours

Various Speakers

Personalized Patient Immunotherapy: Integrating Biomarkers into Clinical Practice

12 episodes - 2.00 credit hours

Various Speakers

Ushering in Maintenance Therapy for AML

11 episodes - 1.75 credit hours

Various Speakers

Integrating and Optimizing Immunotherapy-Based Combinations in mccRCC

6 episodes - 1.25 credit hours

Various Speakers

Changing the Treatment Paradigm for Patients with Intermediate- and Higher-Risk MDS

8 episodes - 1.25 credit hours

Various Speakers

Contemporary Challenges and New Approaches in Metastatic Melanoma

9 episodes - 1.75 credit hours

Various Speakers

New and Emerging Approaches to Managing Lower-Risk MDS

10 episodes - 2.00 credit hours

Various Speakers

IO Advances in Upper Gl Cancers: Integrating Data from Fall 2020 Meetings into Clinical Practice

12 episodes - 2.00 credit hours

Various Speakers

TKI’s and Immune Checkpoint Inhibitors: The New Foundation in Metastatic Clear-cell Renal Cell Carcinoma (mccRCC)

13 episodes - 2.00 credit hours

Various Speakers

Frontline Systemic Therapy for Metastatic Melanoma

7 episodes - 1.00 credit hour

Various Speakers

Navigating First-Line Checkpoint Inhibitor Combinations in Non-Small Cell Lung Cancer (NSCLC) in the Era of COVID-19

12 episodes - 2.00 credit hours

Various Speakers

Advances in First-Line NSCLC: Integrating the Latest Congress Data into Clinical Practice

3 episodes - 0.50 credit hours

Various Speakers

Gastrointestinal Cancers (GI) 3 items

IO On The GO Series: Clinical Questions and Latest Approaches in Hepatocellular Carcinoma (HCC)

5 episodes - 1.00 credit hour

Various Speakers

Personalized Patient Immunotherapy: Integrating Biomarkers into Clinical Practice

12 episodes - 2.00 credit hours

Various Speakers

IO Advances in Upper Gl Cancers: Integrating Data from Fall 2020 Meetings into Clinical Practice

12 episodes - 2.00 credit hours

Various Speakers

Genitourinary Cancers (GU) View All (7)

Latest Immunotherapy Advances in RCC: Integrating Data from the 2021 Winter Meeting into Clinical Practice

6 episodes - 1.00 credit hour

Various Speakers

Immunotherapy Advances in Urothelial Cancer: Integrating Data from the Winter 2021 Meeting into Clinical Practice

7 episodes - 1.00 credit hour

Various Speakers

Impacting Patient Outcomes in mRCC

9 episodes - 1.50 credit hours

Various Speakers

Personalized Patient Immunotherapy: Integrating Biomarkers into Clinical Practice

12 episodes - 2.00 credit hours

Various Speakers

Integrating and Optimizing Immunotherapy-Based Combinations in mccRCC

6 episodes - 1.25 credit hours

Various Speakers

Advances in Genitourinary Cancers: Integrating Data into Clinical Practice and COVID-19 Consideration

5 episodes - 1.00 credit hour

Various Speakers

TKI’s and Immune Checkpoint Inhibitors: The New Foundation in Metastatic Clear-cell Renal Cell Carcinoma (mccRCC)

13 episodes - 2.00 credit hours

Various Speakers

Bone Marrow/Stem Cell Transplantation View All (6)

Highlights in Hematologic Malignancies from the Winter 2020 Hematology Meeting - Integrating Data into Clinical Practice

9 episodes - 1.25 credit hours

Various Speakers

Advancing the Care of ß-thalassemia Patients with Novel Therapies

14 episodes - 1.75 credit hours

Various Speakers

Personalized Patient Immunotherapy: Integrating Biomarkers into Clinical Practice

12 episodes - 2.00 credit hours

Various Speakers

Ushering in Maintenance Therapy for AML

11 episodes - 1.75 credit hours

Various Speakers

Changing the Treatment Paradigm for Patients with Intermediate- and Higher-Risk MDS

8 episodes - 1.25 credit hours

Various Speakers

New and Emerging Approaches to Managing Lower-Risk MDS

10 episodes - 2.00 credit hours

Various Speakers

Anticoagulation Management & Reversal View All (12)

The Bleeding Patient in the Emergency Department, Evidence-Based Approaches

2 episodes - 0.50 credit hours

Natalie Kreitzer, MD, MS

Managing Intracranial Hemorrhages in the Presence of Anticoagulation

3 episodes - 0.50 credit hours

Fred Rincon, MD, MSc, MBE

Case Studies in Hemorrhagic Stroke Management - What Should be Done?

4 episodes - 0.50 credit hours

Anmar Razak, MD

Time is Brain: The Management of Hemorrhagic Strokes and Role of Comprehensive Stroke Centers

7 episodes - 1.00 credit hour

Various Speakers

Translating CAT Guidelines into Everyday Practice During COVID-19

8 episodes - 1.25 credit hours

Various Speakers

Identifying Patients with PAD - Assessing Risk and Screening Patients

10 episodes - 1.50 credit hours

Various Speakers

Redefining the Coordination for VTE - Site of Care, Clinicians, and Patients – Part 2

10 episodes - 1.00 credit hour

Various Speakers

Redefining the Coordination for VTE - Site of Care, Clinicians, and Patients

12 episodes - 1.50 credit hours

Various Speakers

Casual and Educational Debriefs with Anticoagulation Experts at ISTH 2020

5 episodes - 1.25 credit hours

Various Speakers

Management of Life-Threatening Bleeding in the Anticoagulated Patient in the Emergency Department

9 episodes - 2.75 credit hours

Various Speakers

Integrating Health Economics into Clinical Practice for the Reversal of an Anticoagulated Patient

6 episodes - 1.00 credit hour

Various Speakers

Holding Court in Anticoagulation Reversal

11 episodes - 2.00 credit hours

Various Speakers